MS
OMGA

Maven Securities’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Maven Securities’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-147,750
Closed -$2.79M – 1209
2021
Q3 		$2.79M Buy
+147,750
New +$2.83M 0.09% 173

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Maven Securities's OMGA Position: Q4 2021 in Review

Maven Securities sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q4 2021, closing a stake of 147,750 shares — an estimated $2.79M sold.

Maven Securities first reported a position in OMGA in Q3 2021 and held it in 1 quarter. The position peaked at $2.79M in Q3 2021. 45 funds tracked by Wall St. Rank hold OMGA as of Q4 2021.

  • Maven Securities reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Maven Securities sold 147,750 Omega Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $2.79M.
  • Maven Securities first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Maven Securities's Omega Therapeutics, Inc. Common Stock position peaked at $2.79M in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Maven Securities's 13F filing for Q4 2021, filed 14 Feb 2022.